Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Spending reports summarize where money goes and where to cut back. Convert findings into concrete budget adjustments that sustain progress.
19,889 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
In the AI inference era, memory and efficiency win more than raw compute. This sleeping semiconductor giant sits pois...
J.P. Morgan's strategists raise their year-end S&P 500 view to 7,800, citing stronger earnings and resilient consumer...
Dividend income investors watch yields closely. This article explains how yields move, why this dividend ETF's yield ...
As Samsara charts its path in the IoT space, the focus turns to 2026 earnings and what they signal for growth, profit...
The latest weekly data show the number people getting unemployment dropping to a 2½-year low, as initial claims ease ...
AMC Networks reports Q1 2026 results that hinge on streaming momentum and disciplined costs. This piece breaks down t...
A near-retiree faced a devastating financial blow after a crypto scam. This guide explains how the loss happened, how...
A practical, reader-friendly guide to what to expect in evaxion (evax) 2025 earnings. Learn the drivers, read the cal...
Coty is navigating a shifting beauty market. This guide breaks down coty (coty) 2026 earnings, what the Q3 transcript...
A high-net-worth retiree with a $2.1 million 401(K) moves to Nevada to minimize state taxes before his first RMD at 7...
When one tech giant climbs and another stumbles, the market often stays coldsweat steady. Learn how Micron’s strength...